📰 Express Genes News
Express Genes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Express Genes. Real-time updates on events, politics, business and more.
May 3, 2024
Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued growth momentum. Analysts reaffirm Outperform ratings.
February 2, 2024
Revenue Surges 32% Year-Over-Year; Gross Margin Guidance Increased
February 2, 2024
Twist Bioscience reported Q1 2024 earnings, beating revenue guidance and increasing FY24 guidance. Shares are up 7.16%.
February 2, 2024
– Record revenue of $71.5M in 1QFY24, an increase of 32% over $54.2M in 1QFY23 – – Orders increased to $77.5M in 1QFY24, an increase of 19% over 1QFY23 – — Increased FY 2024 revenue...
January 25, 2024
In this article, we will take a detailed look at the 15 Stocks That Will Outperform the S&P 500 in 2024. For a quick overview of such stocks, read our article 5 Stocks That Will Outperform the S&P 500 in 2024. All indicators show that the US economy remains resilient and in a much better shape than expected, […]
January 25, 2024
In this article, we will take a detailed look at the 15 Stocks That Will Outperform the S&P 500 in 2024. For a quick overview of such stocks, read our article 5 Stocks That Will Outperform the S&P ...
January 24, 2024
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express...
January 17, 2024
These are the stocks posting the largest moves in premarket trading.
January 17, 2024
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing revenue and profit margins.
November 20, 2023
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2023 Earnings Call Transcript November 17, 2023 Twist Bioscience Corporation beats earnings expectations. Reported EPS is $-0.81, expectations were $-0.94. Operator: Welcome to the Twist Bioscience’s Fiscal 2023 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that […]